Pediatric Bipolar Disorder
7
1
1
1
Key Insights
Highlights
Success Rate
25% trial completion
Treatment Research
7 treatments under study, led by Aripiprazole
Research Leaders
7 sponsors active, led by Massachusetts General Hospital
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
42.9%
3 terminated out of 7 trials
25.0%
-61.6% vs benchmark
43%
3 trials in Phase 3/4
300%
3 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (7)
Greater Houston Area Pediatric Bipolar Registry
Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder
Screening Protocol for Children and Adolescents With Bipolar and Bipolar Spectrum Disorder
Retrain Your Brain in Children/Adolescents With Bipolar Disorder: A Pilot Study
Invega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar Disorder
Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents
Omega 3 Fatty Acid Trial
Research Network
Common Treatments
- Aripiprazole1
- Fluoxetine1
- Fish Oil1
- Cogflexcontrol Condition1
- Paliperidone1
Active Sponsors
- Massachusetts General Hospital4
- The University of Texas Health Science Center, Houston1
- National Institute of Mental Health (NIMH)1
- Bradley Hospital1
- Mayo Clinic1
Top Investigators
Massachusetts General Hospital
The University of Texas Health Science Center, Houston
MGH
Mayo Clinic
Massachusetts General Hospital
Related Conditions
- Adolescent Bipolar Disorder1
- Omega3 Fatty Acids1
- Pediatric Ocd1
- Childhoodonset Bipolar Disorder1
- Magnetic Resonance Spectroscopy Imaging1